Rocket Pharmaceuticals, Inc. SEC filings RCKT
Rocket Pharmaceuticals, Inc. has 968 filings in SEC EDGAR's recent list, going back to Feb 25, 2004. Its latest annual report, Form ARS, was filed on Apr 6, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 10, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 6, 2026 (material agreement, new debt, unregistered share sale, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 25-NSE | Delisting notice | Sep 2, 2026 | — |
| SC TO-I/A | Filing | May 28, 2026 | — |
| SC TO-I | Filing | Apr 27, 2026 | — |
| SC TO-C | Filing | Apr 3, 2026 | — |
| EFFECT | Filing | Mar 10, 2026 | — |
| CORRESP | Letter to the SEC | Mar 6, 2026 | — |
| UPLOAD | Letter from the SEC | Mar 6, 2026 | — |
| EFFECT | Filing | May 8, 2023 | — |
| CERT | Filing | Feb 24, 2023 | — |
| 8-A12B | Filing | Feb 24, 2023 | — |
| EFFECT | Filing | Oct 31, 2022 | — |
| CORRESP | Letter to the SEC | Oct 27, 2022 | — |
| UPLOAD | Letter from the SEC | Oct 19, 2022 | — |
| 425 | Filing | Sep 20, 2022 | — |
| 425 | Filing | Sep 20, 2022 | — |
| 425 | Filing | Sep 20, 2022 | — |
| UPLOAD | Letter from the SEC | Oct 18, 2021 | — |
| CORRESP | Letter to the SEC | Oct 7, 2021 | — |
| UPLOAD | Letter from the SEC | Sep 27, 2021 | — |
| EFFECT | Filing | Sep 10, 2021 | — |
| CORRESP | Letter to the SEC | Sep 8, 2021 | — |
| UPLOAD | Letter from the SEC | Mar 10, 2021 | — |
| DEL AM | Filing | Mar 8, 2021 | — |
| PX14A6G | Filing | May 29, 2020 | — |
| EFFECT | Filing | Jun 24, 2019 | — |
| CORRESP | Letter to the SEC | Jun 21, 2019 | — |
| UPLOAD | Letter from the SEC | Jun 21, 2019 | — |
| CT ORDER | Filing | May 9, 2019 | — |
| CT ORDER | Filing | Dec 6, 2018 | — |
| EFFECT | Filing | Jul 5, 2018 | — |
| RW | Filing | Jun 26, 2018 | — |
| 8-A12B/A | Filing | Jan 11, 2018 | — |
| UPLOAD | Letter from the SEC | Dec 1, 2017 | — |
| CORRESP | Letter to the SEC | Nov 30, 2017 | — |
| UPLOAD | Letter from the SEC | Nov 29, 2017 | — |
| CORRESP | Letter to the SEC | Nov 20, 2017 | — |
| PRER14A | Filing | Nov 20, 2017 | — |
| UPLOAD | Letter from the SEC | Nov 13, 2017 | — |
| 305B2 | Filing | Aug 1, 2016 | — |
| EFFECT | Filing | Apr 14, 2016 | — |
| CORRESP | Letter to the SEC | Apr 12, 2016 | — |
| UPLOAD | Letter from the SEC | Apr 12, 2016 | — |
| EFFECT | Filing | Aug 12, 2015 | — |
| CORRESP | Letter to the SEC | Aug 10, 2015 | — |
| CORRESP | Letter to the SEC | Aug 10, 2015 | — |
| UPLOAD | Letter from the SEC | Aug 7, 2015 | — |
| EFFECT | Filing | Feb 17, 2015 | — |
| CORRESP | Letter to the SEC | Feb 17, 2015 | — |
| CORRESP | Letter to the SEC | Feb 17, 2015 | — |
| CORRESP | Letter to the SEC | Feb 9, 2015 | — |
| CORRESP | Letter to the SEC | Feb 9, 2015 | — |
| CERTNAS | Auto-generated paper document | Feb 4, 2015 | — |
| CORRESP | Letter to the SEC | Feb 3, 2015 | — |
| CORRESP | Letter to the SEC | Feb 3, 2015 | — |
| 8-A12B | Filing | Feb 2, 2015 | — |
| CORRESP | Letter to the SEC | Nov 26, 2014 | — |
| CORRESP | Letter to the SEC | Nov 26, 2014 | — |
| UPLOAD | Letter from the SEC | Nov 26, 2014 | — |
| CORRESP | Letter to the SEC | Nov 21, 2014 | — |
| CORRESP | Letter to the SEC | Nov 21, 2014 | — |
| UPLOAD | Letter from the SEC | Nov 18, 2014 | — |
| CORRESP | Letter to the SEC | Nov 4, 2014 | — |
| UPLOAD | Letter from the SEC | Oct 14, 2014 | — |
| DRS/A | Filing | Sep 29, 2014 | — |
| UPLOAD | Letter from the SEC | Sep 25, 2014 | — |
| DRS | Filing | Aug 29, 2014 | — |
| D/A | Filing | Jul 19, 2011 | — |
| D | Filing | Jun 23, 2010 | — |
| REGDEX | Auto-generated paper document | Sep 10, 2007 | — |
| REGDEX | Auto-generated paper document | Aug 23, 2005 | — |
| REGDEX | Auto-generated paper document | Feb 25, 2004 | — |
Showing 71 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- RCKT (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New York, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1281895
- Former names
- INOTEK PHARMACEUTICALS CORP (until Dec 22, 2017)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.